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malformation in a 15-year-old
girl – the rarest of the rare
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1 Medical College, Aga Khan University, Karachi, Pakistan, 2 Department of Pediatrics, Aga Khan University, Karachi, Pakistan
Introduction: Sarcoidosis is an uncommon multi-system disorder with many possible
complications. Arteriovenous malformations (AVMs) are a rare vascular complication of
sarcoidosis.
Case description: A 15-year-old girl presented to the Pediatric Clinic at AKUH with pul-
monary, hepatic, joint, and skin manifestations. Physical examination and investigations
pointed toward sarcoidosis, including raised erythrocyte sedimentation rate, angiotensin
converting enzyme (ACE), and alanine transaminase (ALT). An incidental finding of
pulmonary arteriovenous malformation (PAVM) was noticed on echocardiography. She
responded to oral corticosteroids, her ACE and ALT levels improved. There was lack of
indication for pulmonary angio-embolization for her PAVM. On a 3-year follow-up, her
condition improved and she is clinically well.
Discussion: Pulmonary arteriovenous malformation is an extremely rare complication of
sarcoidosis, especially among the pediatric population. Hence, this is the first reported
case of its kind. The relation between sarcoidosis and PAVM is difficult to establish;
however, there are some theories. This condition may be treated depending on the
symptoms. Since our patient did not have any significant symptoms of PAVM, she was
treated for the underlying disease, i.e., sarcoidosis.
Conclusion: While dealing with patients having multi-system disorders like sarcoidosis,
one must be very vigilant so as not to miss out on any complication. Regular follow-up
visits should be scheduled to rule out new complications and to monitor the past ones.
Keywords: sarcoidosis, AVMs, pulmonary arteriovenous malformations, pulmonary sarcoidosis, complications of
sarcoidosis
Introduction
Sarcoidosis is a rare disorder characterized by non-caseating granulomas in multiple organs. There
is no definite known cause (1). Most patients present with lung, eye, and skin manifestations though
any part of the body can be involved (2). Varying degrees of severity and complications have been
seen among patients. Pulmonary, ocular, and neurological are some of the more common compli-
cations found (2). Rarely, vascular complications are seen (2). In turn, arteriovenous malformations
(AVMs) are abnormal communications between arteries and veins, most commonly found in the
brain (3). Pulmonary AVMs are very rare. It can present with dyspnea, hemoptysis, and platypnea.
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Most are due to underlying hereditary telangiectasia (4). We
report a case of a 15-year-old girl with sarcoidosis found to have
pulmonary AVMs, an extremely rare complication.
Case Presentation
A 15-year-old Pakistani girl reported to our clinic with complaints
of generalized rash, painful swollen small joints, and cyanosis
since 2 years of age. She also complained of low grade fever,
breathlessness, and fatigue. Examination revealed an emaciated,
anemic, centrally cyanosed girl with weight and height below
5th percentile. Oxygen saturation was 84% and respiratory rate
24/min. Grade IV clubbing was present. Generalized, erythe-
matous, maculopapular rash was present, mostly on the trunk.
Tender, swollen joints were also found with limited range of
movement. Abdominal exam showed gross hepatosplenomegaly
and positive shifting dullness. Chest and precordium exams were
normal. Initial assessment of autoimmune disease, cyanotic heart
disease, systemic vasculitis, and failure to thrive was made.
Initial laboratory workup showed hemoglobin (Hb): 11.3 g/dl,
hematocrit (HCT): 35.7%, white blood cells (WBC): 6.1 109
(PMN: 57.4%, L: 34.5%), Platelets: 306 109; all within the nor-
mal range. Her erythrocyte sedimentation rate (ESR) was raised
(35mm in first hour), along with alanine transaminase (ALT),
which was 164 IU/l, gamma-glutamyl transpeptidase (GGT),
which was 148 IU/l, and alkaline phosphatase (AP), which was
553 IU/l. Viral markers for hepatitis (B and C) were non-reactive.
Autoimmune profile [anti-nuclear antibody (ANA), anti-DNA,
Anti-mitochondrial antibody (AMA), anti-smooth muscle anti-
body (ASMA), rheumatoid factor (RF), cytoplasmic anti-nuclear
cytoplasmic antibody (c-ANCA), and perinuclear anti-nuclear
cytoplasmic antibody (p-ANCA)] was negative. Chest x-ray was
normal. Ultrasound of abdomen showed an enlarged spleen
(13 cm) and an enlarged liver with normal echotexture. Liver
biopsy revealed moderate portal lobular inflammation (Grade 3)
and peri-portal fibrosis (Stage 2). Skin biopsy revealed histio-
cytic reaction with multinucleated giant cells with no evidence
of telangiectasia or vasculitis, thus suggesting chronic granuloma-
tous disease. Further investigations were done on the lines of sar-
coidosis. Expectedly, angiotensin converting enzyme (ACE) level
was raised with a value of 100U/l (normal: <52U/l); however,
serum calcium was normal at 8.9mg/dl (normal: <10.5mg/dl).
The eye exam did not reveal any abnormality.
Echocardiography was done to investigate cyanosis and breath-
lessness. Conventional echocardiography ruled out any structural
lesions of the heart but bubble echocardiography showed contrast
bubbles in left atrium after three cardiac cycles, suggestive of
pulmonary AV malformation (Figure 1). CT angiogram was thus
done and revealed three soft tissue density nodules. These were in
the right upper lobe, right lower lobe, and a smaller one in the left
lower lobe. Vessels were seen to be arising from the nodules. No
signs of infection of interstitial lung disease were seen (Figure 2).
All these findings were complementing pulmonary arteriovenous
malformation (PAVM).
Final assessment of sarcoidosis with PAVM was made. She
was started on oral steroids and monitored closely. ACE and
ALT levels declined significantly over the next few weeks to
FIGURE 1 | A pulmonary AVM as seen on echocardiogram.
FIGURE 2 | Coronal CT images showing AVM on right and left side
(arrow).
53 (normal: <52) and 65 (normal: <35), respectively. Hep-
atosplenomegaly began to regress. Her cyanosis and exertional
dyspnea improved gradually too. It was decided to not carry out
pulmonary angio-embolization as she hadmultiple AVmalforma-
tions and it was less likely to benefit her. On a 3-year follow-up, she
was clinically stable with no active symptoms and her laboratory
parameters were back to normal.
Discussion
Pediatric sarcoidosis is an infrequent condition. A Danish study
has reported an incidence of 0.29 cases per 100,000 children as
opposed to 5–40 cases per 100,000 adults (5, 6). PAVM is also
a unique occurrence and so far no studies have established a
pediatric prevalence of the disease, though the prevalence in adults
is reported to be 2–3 per 100,000 population (6). Most cases of
pediatric PAVM occur in children with underlying hereditary
hemorrhagic telangiectasia (5). Thus, to come across a case in
which sarcoidosis is complicated by PAVM is extremely rare.
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In our literature search, we found only one such case reported
from Japan of a 27-year-old woman (7). No such pediatric cases
have been reported so far and this is the first of its kind.
The relation between sarcoidosis and PAVM is extremely dif-
ficult to establish. Both diseases have an unknown etiology (3,
5). Current theories postulate that most PAVMs are caused by
defects during vascular development in the fetus, such as aber-
rant TGF-beta signaling or a defect in terminal arterial loops
(3). No theory has thus far suggested a cause for non-congenital
PAVMs (3). On the other hand, there are numerous etiological
theories for the occurrence of sarcoidosis, including environ-
mental triggers, infectious agents, T-cell abnormalities, and effect
of cytokines, such as TNF alpha (8, 9). No common etiological
factors for the disease were found, which makes it very difficult
to understand how the two disease processes occurred together
in our patient. We could theorize, however, that certain pro-
inflammatory cytokines released in sarcoidosis could have led to
progressive vasodilation of thin-walled capillary sacs, formation
ofmulti-loculated sacs, and finally rupture of intervening vascular
walls leading to formation of small PAVMs. Further research is
required to establish a relation between the two.
It is also a known fact that cirrhosis has an association with
PAVM(5, 10). This association has been termedhepatopulmonary
syndrome (HPS) and is defined by liver dysfunction or portal
hypertension, intrapulmonary vascular dilations, and abnormal
gas exchange (11). The vascular component of HPS may include
pulmonary capillary dilatation or macrovascular AVMs (12, 13).
In our case, the patient had hepatomegaly and biopsy also revealed
signs of moderate cirrhosis, which is another cause of formation
of PAVM (14). Thus, we can also postulate that PAVMs devel-
oped in this patient secondary to cirrhosis, which itself was a
manifestation of the granulomatous processes of sarcoidosis.
Pulmonary arteriovenous malformation can be diagnosed on
contrast-enhanced transthoracic echocardiography with saline. In
this procedure, saline is injected into a peripheral vein and the
subsequent changes in both the atria are noted. In the case of an
intracardiac shunt, bubbles will be visualized in the left atrium
within one cardiac cycle after their appearance in the right atrium,
while with PAVMs bubbles in the left atrium will appear after a
delay of three to six cardiac cycles, as was the case in our patient
(12). Diagnosis of PAVM is further confirmed by using pulmonary
angiography (12).
Clubbing is a sign that indicates severe, chronic, or multi-
ple PAVMs. Review of data based on the six largest consec-
utive case-series of PAVMs during the past 50 years, revealed
that the average incidence of clubbing in PAVMs was 5% (15).
Most pathologies causing long-term cyanosis and clubbing are
picked up on echocardiography, e.g., intracardiac shunts. How-
ever, extracardiac shunts are better picked up on contrast echocar-
diography. With a sensitivity of 100% and a specificity of 49%,
contrast echocardiography is the recommended first investigation
of choice to diagnose PAVMs and preferred over any other meth-
ods including 100% oxygen method and radionuclide perfusion
scanning (15).
Literature has shown that PAVMs do not regress on their own.
Most remain stable and 25% enlargewith time (16). Themorbidity
andmortality are uncertain but it is known thatmost deaths occur
due to stroke, cerebral abscess, or hemothorax (16, 17). That being
said, not all PAVMs require treatment. Indications for treatment
have been not clearly defined and a final decision is made by
comparison of risk of complications versus risk of treatment pro-
cedures. In our patient, the CT showed PAVMs that were small in
size (6mm 5mm), which did not require any intervention (8,
11, 16). She will be followed with a CT in the future to look for
enlargement and to recognize any worsening symptoms. If found
then treatment with pulmonary angio-embolization will be the
first choice.
Conclusion
When dealing with a multi-systemic disease, such as sarcoidosis,
which can involve almost any part of the body, one must be
vigilant while evaluating a patient. While one can be extremely
thorough in the evaluation of a patient, there is always a limit
and one should keep an open mind of what one may find.
The echocardiography done in this case, incidentally found
the PAVM. It is important that the physician keep a regular
follow-up of patients with PAVM so as to prevent any possible
complications.
Consent
Written informed consent to share information and images in this
case report was obtained from the patient prior to publication.
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